NCT01388283

Brief Summary

The purpose of this study is to assess the predictive role of serum inflammatory markers in pregnant women who subsequently develop preeclampsia.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
129

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 1999

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 1999

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2004

Completed
7.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2011

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

June 30, 2011

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 6, 2011

Completed
Last Updated

July 6, 2011

Status Verified

June 1, 2011

Enrollment Period

5.3 years

First QC Date

June 30, 2011

Last Update Submit

July 5, 2011

Conditions

Preeclampsia

Keywords

prognostic marker

Eligibility Criteria

Age20 Years - 43 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Case-control study consisting of 43 women developping preeclampsia and 86 women not developping this disorder. All were of Caucasian origin and were nulliparous.

You may qualify if:

  • caucasian,
  • nulliparous

You may not qualify if:

  • preexisting cardiovascular diseases,
  • diabetes,
  • hypertension,
  • inflammatory bowel diseases,
  • serious organ diseases, and
  • development of separate gestational diabetes and/or hypertension.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Biospecimen

Retention: SAMPLES WITHOUT DNA

serum

MeSH Terms

Conditions

Pre-Eclampsia

Condition Hierarchy (Ancestors)

Hypertension, Pregnancy-InducedPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

June 30, 2011

First Posted

July 6, 2011

Study Start

January 1, 1999

Primary Completion

May 1, 2004

Study Completion

June 1, 2011

Last Updated

July 6, 2011

Record last verified: 2011-06